Sirtuin Modulators for Broad-Spectrum Antiviral Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate in effectively inhibiting the production of infectious viruses such as HCMV, HSV1, adenovirus, and influenza A, as they fail to target the sirtuin family of proteins, which play a crucial role in viral replication.
Innovation Solution
Development of sirtuin agonists and antagonists, including polyhydroxy stilbene compounds, flavonoids, and specific inhibitors like cambinol and tenovin, to modulate the activity of sirtuins, thereby inhibiting virus production by targeting SIRT1, SIRT2, and other sirtuins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current antiviral methods are used, then virus production is not effectively inhibited, but the lack of sirtuin targeting reduces therapeutic efficacy
Solution Approach 1:
The patent applies universality by developing sirtuin modulators that can inhibit multiple virus types (HCMV, HSV1, adenovirus, influenza A) through a common mechanism of action. The compounds target the conserved sirtuin family of proteins, which are essential for viral replication across different virus families, thereby achieving broad-spectrum antiviral activity with a single class of agents
Solution Approach 2:
The patent uses sirtuin proteins as intermediary targets between the antiviral compounds and viral replication processes. Rather than directly targeting viral components, the modulators act on host sirtuin proteins that are required for viral replication, creating a indirect but effective inhibition mechanism that achieves reliable therapeutic efficacy
2Productivity
If sirtuin agonists are used, then virus production is reduced, but the complexity of identifying effective compounds increases
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structures of known sirtuin-interacting compounds (such as resveratrol derivatives) to optimize their antiviral activity. By systematically varying molecular parameters like hydroxyl group positions and substitutions on the stilbene backbone, the invention identifies compounds with enhanced potency against viral replication while maintaining sirtuin binding capability
Data Source
AI summary
Agents and methods of inhibiting or improving the growth of viruses are provided.